2MWT
OtherTwo minutes walk tests.
Other names: Two minutes walk tests
NCT Number: NCT05798325
The low prevalence of rare diseases hinders the design of clinical studies with sufficient statistical power to demonstrate the efficacy of new drugs. This can only be achieved by setting up international multicentre studies, which is challenging due to a lack of objective, universal outcome measures that generate high-quality, reproducible data. One of the hurdles in attaining universal outcome measures for clinical trials is the difficulty to capture and distinguish ambulatory from non-ambulatory, autonomous and assistive or involuntary movements. This makes a trial assessing the ambulatory phase very challenging at this moment. Excluding many participants from trials and many patients from access to medication.
Integration and validation of the technology in trials, research and patients' lives is essential in overcoming this hurdle. For example, in dystrophinopathies separate outcome measures exist for ambulant and non-ambulant participants, but the relation between these outcome measures or a transitional outcome measure/end point is largely missing.
Following an exhaustive literature review, several tools have been selected to remotely follow various symptoms of neuromuscular patients including weakness, pain, fatigue, cognitive defects, motor impairments (including loss of dexterity, ataxia...), metabolic, respiratory and cardiac troubles, contractures, tremor, falls, hypo or hypersomnia... The toolbox includes common measures for all patients but may include additional measures specific to the patient's symptoms (hence in turn to the patients' disease).
The measurements are designed to not be invasive, intrusive or burdensome for the patient.
DT4RD is going to leverage state-of-the art technology, clinical rating scales and psychometric/data analysis to deliver fit for purpose remote clinical assessments of mobility to ensure maximum patient benefit, specifically:
* Compare face to face clinical data collected in hospital with Patient Generated Data recorded remotely * Examine how sensors can enhance measurement potentially at home and during clinical visits * Promote a clear focus on user centered design and the integration of technology * Use reliability and validity analyses to equate any common measures (those with the same or a similar construct) * Demonstrate a proof-of-concept model into which different measures can be interchangeable
Looking for future studies?
Notify Me12 year–60 year
All sexes
Interventional
Not applicable
Association Institut de Myologie, Paris, France
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Two minutes walk tests.
Other names: Two minutes walk tests
Motor Function Measurement (MFM) is a quantitative scale created to measure global motor functional abilities in a person with neuromuscular disease.
Other names: Muscle Motor Function 32
The MyoGrip is a dynamometer for measuring grip strength.
The "Quality of Life in genetic Neuromuscular Disease" questionnaire (QoL-gNMD) is a patient reported outcome measure (PROM) tool specifically designed for patients with a lowly progressive neuromuscular disease with genetically predominant muscular damage
Forced vital capacity (FVC), peak expiratory flow (PEF) and forced expiratory volume in 1 second (FEV1) will be measured in the hospital with the local hospital device (e.g. Vitalograph) under the supervision of the clinical evaluator, and at home with a portable device.
Other names: Spirobank Smart
The Links sensor system is a measuring device and consists of the Links Pods and the Links Hub. The Links pods contain an accelerometer, gyroscope and magnetometer to measure position relative to a global reference frame.
Other names: Links sensor system
10 meters walking Test.
The Performance of the Upper Limb (PUL) is a functional scale specifically designed for assessing upper limb function in Duchenne muscular dystrophy.
Other names: Performance of Upper Limb
The North Star Ambulatory Assessment (NSAA) is a 17-item rating scale that is used to measure functional motor abilities in ambulant children with Duchenne Muscular Dystrophy.
Other names: North Star Ambulatory Assessment
The NSAD was developed to measure motor performance in ambulant and non-ambulant subjects as part of the clinical outcome study of dysferlinopathy.
Other names: North Star Assessment for limb-girdle type muscular dystrophies
This scale is derived from the North Star Ambulatory Assessment and several items from the Egan Klassifikation Scale (EK2).
Other names: Transition Assessment North Star
The MyoPinch is a high-precision dynamometer that allows the evaluation of key pinch strength.
The MyoQuad is a high-precision dynamometer that allows the evaluation of knee extension strength.
Activity limitations, as measured by ACTIVLIM, is defined as the difficulties a patient may have in executing daily activities, whatever the strategies involved.
This questionnaire is made up of simple questions relating to the assessments and assessment tools that were used during the study.
Other names: Patient Reported Experience Measures
The main component of the SF-MPQ consists of 15 descriptors (11 sensories; 4 affective) which are rated on an intensity scale as 0 = none, 1 = mild, 2 = moderate or 3 = severe.
Other names: Modified Short-form McGill Pain Questionnaire
The Fatigue Severity Scale is used to assess the severity of fatigue and its impact on daily living. The patient responds on a Likert-type scale ranging from 1 to 7.
Other names: Fatigue Severity Scale
This questionnaire assesses overall physical activity and the level of sedentary lifestyle during the last seven days.
Other names: International Physical Activity Questionnaire
The EasyAngle® is a digital goniometer improving long established goniometric functionality with rotation, inclination, and scoliosis measurement capabilities.
Other names: EasyAngle
The Links sensor system is a measuring device and consists of the Links Pods and the Links Hub. The Links pods contain an accelerometer, gyroscope and magnetometer to measure position relative to a global reference frame.
Other names: Links Sensor System goniometers
Once every four weeks, while wearing the Yumen electronic goniometers (Links Sensor System), the patients will be asked to record on video three tasks related to:
Wearable devices (connected watch) will collect health-related data on a 24/7 basis remotely as patients go through their daily routines at home and work.
Other names: Activity assessment and physiological parameters
Time frame: Through study completion, an average of 1 year
Proportion of home assessments carried out compared to the number of home assessments planned
Time frame: Through study completion, an average of 1 year
Analysis of the proportion of replies to the questionnaires at home
Time frame: Through study completion, an average of 1 year
Analysis of the proportion of valid spirometry data collected at home
Time frame: Through study completion, an average of 1 year
Analysis of the proportion of usable accelerometry data collected at home
Time frame: Through study completion, an average of 1 year
Analysis of the proportion of usable data collected at home using the smartwatch
Time frame: Through study completion, an average of 1 year
Analysis of the usability of the video tasks performed at home
Time frame: Through study completion, an average of 1 year
Comparison of Forced vital capacity data collected during home and hospital spirometer measurements
Time frame: Through study completion, an average of 1 year
Comparison of Peak expiratory flow data collected during home and hospital spirometer measurements
Time frame: Through study completion, an average of 1 year
Comparison of forced expiratory volume in 1 second data collected during home and hospital spirometer measurements
Institut de Myologie, France
Other
Feasibility, Validation and Application of Digital Tools for the Follow-up of Neuromuscular Patient
Acronym: DT4RD
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06367686
Apnea, Chronic Disease
Tønsberg, Norway
View Trial DetailsNCT05070624
Nervous System Diseases, Neuromuscular Diseases
Toronto, Ontario, Canada
View Trial DetailsNCT02789059
Amyotrophic Lateral Sclerosis, Central Nervous System Diseases
Amiens, France
View Trial DetailsNCT03179631
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn
Phoenix, Arizona, United States
View Trial Details